Showing 1 - 1 results of 1 for search 'Vanask, T', query time: 0.01s
Refine Results
-
1
PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease by Keshav, S, Petryka, R, Vanask, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Machado, M, Dahlerup, J, Schreiber, S, Bekker, P, Sankar, S, Schall, T
Published 2007Conference item